GGrantIndex
← Leaderboards

Mohini Ranganathan

Yale University

$2,625,379
Attributed
$4,532,771
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $945.2K · FY201123
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$4,532,771 · 5

By mechanism

R01$2,942,206 · 1
R21$1,590,565 · 4

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Cannabis

Research focus

CannabisCannabinoidsDesignPlacebosBaseAgonistVerbal LearningIndexingShort-Term MemoryBrainReceptorPilot ProjectsPreclinical StudyDosePhysiologicalPositron-Emission TomographyChronicBindingLigandsMediatingAnimalsInterestAcuteIn Vivo

Grant awards (14)

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)$51,979
R21 · FY2023 · AT
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$221,251
R21 · FY2020 · AT
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$209,375
R21 · FY2020 · AT
Multimodal Imaging of Recovery from Cannabis Dependence$719,989
R01 · FY2019 · DA
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$29,999
R21 · FY2019 · AT
Multimodal Imaging of Recovery from Cannabis Dependence$730,533
R01 · FY2018 · DA
Multimodal Imaging of Recovery from Cannabis Dependence$740,837
R01 · FY2017 · DA
Multimodal Imaging of Recovery from Cannabis Dependence$750,847
R01 · FY2016 · DA
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans$194,386
R21 · FY2016 · DA · contact PI
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans$163,625
R21 · FY2015 · DA · contact PI
Characterization of the Response to the Kappa Opiate Agonist Salvinorin A in Heal$163,625
R21 · FY2012 · DA · contact PI
Cannabidiol Modulation of ???-9-THC???s Psychotomimetic Effects in Healthy Humans$163,625
R21 · FY2012 · DA · contact PI
Cannabidiol Modulation of ???-9-THC???s Psychotomimetic Effects in Healthy Humans$196,350
R21 · FY2011 · DA · contact PI
Characterization of the Response to the Kappa Opiate Agonist Salvinorin A in Heal$196,350
R21 · FY2011 · DA · contact PI